Preclinical study shows long-term suppression of seizures

Nerve cells communicate with one another via signaling molecules. The rule is: the more of these molecules, the stronger the signal. Drugs and diseases influence these processes and can weaken or strengthen the signal. Together with colleagues of…

Asahi Kasei Pharma will launch a grant for joint research or research development mainly on drug discovery seeds and technologies.

• Open call starts from 5.00 am (GMT) 7th January 2020
• The deadline is at 8.00am (GMT) 26 February 2020
• Areas…

The call addresses representatives from research organizations and those from SMEs and start-ups who develop application-oriented technologies and/or processes. 10 tandems - consisting of one representative from the research sector and one from a SME…

Translation is the key focus at the Berlin Institute of Health (BIH). The aim is to transfer promising results from the laboratory to clinical practice, and to use observations from daily clinical routine as inspiration for new research ideas. For…

ProBioGen AG and Ceva Santé Animale announce the signature of an exclusive license agreement for the manufacture of vectorised poultry vaccines using ProBioGen’s proprietary AGE1.CR® technology.

ProBioGen and Ceva have a long track record of…

Clovis to acquire rights to discovery program for three additional targets for radionuclide therapy

▪ Clovis to pay approximately $12 million in upfront payments to 3B Pharmaceuticals

▪ Clovis currently planning to file an IND for…

Researchers from Charité – Universitätsmedizin Berlin and the German Cancer Consortium (DKTK) have successfully solved a longstanding problem in the diagnosis of head and neck cancers. Working alongside colleagues from Technische Universität (TU)…